Free Trial

Proficio Capital Partners LLC Purchases Shares of 18,200 Azenta, Inc. (NASDAQ:AZTA)

Azenta logo with Medical background
Remove Ads

Proficio Capital Partners LLC acquired a new position in shares of Azenta, Inc. (NASDAQ:AZTA - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 18,200 shares of the company's stock, valued at approximately $910,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in AZTA. KBC Group NV boosted its stake in Azenta by 48.5% in the 4th quarter. KBC Group NV now owns 2,137 shares of the company's stock worth $107,000 after purchasing an additional 698 shares during the period. Assenagon Asset Management S.A. acquired a new position in shares of Azenta during the fourth quarter worth about $200,000. Empowered Funds LLC bought a new position in shares of Azenta during the fourth quarter worth about $293,000. Stephens Inc. AR acquired a new stake in Azenta in the 4th quarter valued at approximately $313,000. Finally, Virtu Financial LLC acquired a new stake in Azenta in the 3rd quarter valued at approximately $352,000. 99.08% of the stock is currently owned by institutional investors and hedge funds.

Azenta Stock Down 2.8 %

Shares of NASDAQ:AZTA traded down $1.08 during midday trading on Tuesday, hitting $37.15. The stock had a trading volume of 411,645 shares, compared to its average volume of 585,142. Azenta, Inc. has a 12 month low of $35.56 and a 12 month high of $63.58. The business's 50-day simple moving average is $46.42 and its 200-day simple moving average is $46.57. The company has a market cap of $1.70 billion, a P/E ratio of -12.47 and a beta of 1.52.

Remove Ads

Azenta (NASDAQ:AZTA - Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.08 EPS for the quarter, beating analysts' consensus estimates of $0.05 by $0.03. Azenta had a negative net margin of 24.91% and a positive return on equity of 1.25%. As a group, equities analysts predict that Azenta, Inc. will post 0.53 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the stock. Stephens reaffirmed an "overweight" rating and set a $60.00 price target on shares of Azenta in a research note on Thursday, January 2nd. TD Cowen raised shares of Azenta to a "hold" rating in a research report on Thursday, February 27th. Needham & Company LLC boosted their price target on shares of Azenta from $55.00 to $59.00 and gave the stock a "buy" rating in a research report on Thursday, February 6th. Finally, Evercore ISI raised their price objective on Azenta from $50.00 to $52.00 and gave the company an "in-line" rating in a report on Thursday, February 6th. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to MarketBeat, Azenta currently has an average rating of "Hold" and a consensus target price of $58.75.

Check Out Our Latest Research Report on AZTA

Azenta Profile

(Free Report)

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.

Featured Stories

Institutional Ownership by Quarter for Azenta (NASDAQ:AZTA)

Should You Invest $1,000 in Azenta Right Now?

Before you consider Azenta, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Azenta wasn't on the list.

While Azenta currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

Recent Videos

WWE Stock Could Explode Next Week — Now’s the Time to Buy Into TKO
These 3 Dividend Stocks Might Be the Safest Bet Right Now
5 International Stocks to Escape U.S. Market Volatility

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads